Delivery Order SPE2DB25D3006-SPE2DB25FXJNU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,921.52 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, designated as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,410.40 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injectors on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injectors on September 3, 2025, with a ceiling value of $1,007.21 and an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed price delivery order represents a single-use contract with no set-aside designation. The award is being fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 31, 2025. This firm fixed-price, competitively awarded delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,785.41 on June 17, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This non-competitive, firm fixed-price delivery order is expected to be completed by June 18, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,443.38 to supply Zepbound 5 mg/0.5 ml pen injectors, with completion targeted for August 20, 2025. This competitive award, issued on August 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16,124.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29.6K to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on September 11, 2025, with completion targeted for September 12, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters location in...
- The Defense Logistics Agency awarded a $3,292.56 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- The Defense Logistics Agency awarded a $4,253.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 22, 2025. This non-competitive delivery order, with an ultimate completion date of July 23, 2025, represents a single-unit pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXJNUDelivery Order
The Defense Logistics Agency awarded a $3,515.84 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injectors on June 18, 2025, with completion expected by June 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order leverages AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with DLA, which enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal contract awards covering specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The Zepbound supply fulfills immediate medical procurement needs for the Defense Health Agency and other federal healthcare systems through the established DLA framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 6/18/25 |